Cargando…

P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

Detalles Bibliográficos
Autores principales: Fried, S., Besser, M. J., Shkury, E., Yerushalmi, R., Shem-Tov, N., Danylesko, I., Jacoby, E., Itzhaki, O., Shouval, R., Kedmi, M., Shimoni, A., Nagler, A., Avigdor, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430686/
http://dx.doi.org/10.1097/01.HS9.0000847300.61295.fe
_version_ 1784779843069542400
author Fried, S.
Besser, M. J.
Shkury, E.
Yerushalmi, R.
Shem-Tov, N.
Danylesko, I.
Jacoby, E.
Itzhaki, O.
Shouval, R.
Kedmi, M.
Shimoni, A.
Nagler, A.
Avigdor, A.
author_facet Fried, S.
Besser, M. J.
Shkury, E.
Yerushalmi, R.
Shem-Tov, N.
Danylesko, I.
Jacoby, E.
Itzhaki, O.
Shouval, R.
Kedmi, M.
Shimoni, A.
Nagler, A.
Avigdor, A.
author_sort Fried, S.
collection PubMed
description
format Online
Article
Text
id pubmed-9430686
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94306862022-08-31 P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA Fried, S. Besser, M. J. Shkury, E. Yerushalmi, R. Shem-Tov, N. Danylesko, I. Jacoby, E. Itzhaki, O. Shouval, R. Kedmi, M. Shimoni, A. Nagler, A. Avigdor, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430686/ http://dx.doi.org/10.1097/01.HS9.0000847300.61295.fe Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Fried, S.
Besser, M. J.
Shkury, E.
Yerushalmi, R.
Shem-Tov, N.
Danylesko, I.
Jacoby, E.
Itzhaki, O.
Shouval, R.
Kedmi, M.
Shimoni, A.
Nagler, A.
Avigdor, A.
P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
title P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
title_full P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
title_fullStr P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
title_full_unstemmed P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
title_short P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
title_sort p1108: high complete response rate following point-of-care anti cd19 car t-cell therapy in patients with relapsed/refractory follicular lymphoma
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430686/
http://dx.doi.org/10.1097/01.HS9.0000847300.61295.fe
work_keys_str_mv AT frieds p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT bessermj p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT shkurye p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT yerushalmir p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT shemtovn p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT danyleskoi p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT jacobye p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT itzhakio p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT shouvalr p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT kedmim p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT shimonia p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT naglera p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma
AT avigdora p1108highcompleteresponseratefollowingpointofcareanticd19cartcelltherapyinpatientswithrelapsedrefractoryfollicularlymphoma